Mylan Pharmaceuticals has signed a settlement agreement with Somaxon Pharmaceutical to resolve patent litigation related to generic version of Somaxon's Silenor. The litigation is regarding Mylan Pharmaceuticals' abbreviated new drug ...
Tags: litigation, generic version of Somaxon's Silenor, ANDA
The US District Court for the District of New Jersey has ruled against Merck, known as MSD outside the US and Canada, in a patent litigation against Apotex. The patent at issue in the case covers the active ingredient in Nasonex, ...
The US District Court for the Southern District of New York has ruled in favor of Teva Pharmaceutical Industries in Copaxone patent infringement litigation. Teva filed lawsuit against Momenta/Sandoz and Mylan/Natco for infringement of ...
Tags: patent, Teva Pharmaceutical Industries, FDA
Perrigo Company has received final FDA approval for its abbreviated new drug application (ANDA) for clindamycin phosphate and benzoyl peroxide 1.2% / 5% topical gel, the generic equivalent of Duac gel. Duac Gel is indicated for the ...
Tags: perrigo company, ANDA, patent litigation
Mylan and its subsidiary, Mylan Pharmaceuticals, have signed a settlement agreement with Pfizer, Pharmacia & Upjohn Company and Pfizer Health related to Detrol LA patent litigation. The litigation is related to Mylan Pharmaceuticals' ...
Hospira has announced the US re-launch of oxaliplatin injection, a generic version of Sanofi's chemotherapy medication Eloxatin. Hospira will initially offer the solution form of oxaliplatin injection in 50mg and 100mg single-use vials, ...
Tags: oxaliplatin injection, Sanofi's chemotherapy medication, oncology drug
lululemon athletica canada inc., a subsidiary of lululemon athletica inc., Calvin Klein, Inc., a wholly owned subsidiary of PVH Corp., and G-III Apparel Group, Ltd., a Calvin Klein, Inc. licensee for Calvin Klein Performance, have entered ...
Tags: United States of America, Lululemon, Calvin Klein, G-III
Meridian Medical Technologies,a Pfizer subsidiary,and Teva have entered into a settlement agreement to resolve generic epinephrine auto-injector pending patent litigation. Under the terms of the agreement,Teva may launch a generic ...
Tags: Epinephrine Auto, Meridian, Teva, generic epinephrine auto-injector
Mylan has reached a settlement in a patent litigation suit filed by Sunovion Pharmaceuticals concerning Mylan Specialty's abbreviated new drug application for Levalbuterol Hydrochloride (HCl) Inhalation Solution, 0.31mg/3 mL, 0.63mg/3 mL, ...
Tags: Sunovion Pharmaceuticals, Medicine
IDG News Service-Analysts say HTC still faces an uphill battle to rebuild its smartphone business amid heated competition,despite reaching a deal with Apple to settle their patent disputes. On Sunday,HTC and Apple announced the dismissal ...
Tags: HTC, Smartphones, Apple
This is a rough time for China in the U.S.Mitt Romney,the Republican presidential candidate,plans to declare on"day one,"if elected,that China is a currency manipulator.A congressional report this month said Chinese intelligence gathering ...
Tags: China, U.S.Mitt Romney, Cisco Systems, Gartner
Nexxus Lighting, Inc. , a market leading manufacturer of LED light bulbs and lighting systems, today announced a settlement agreement ending the pending patent litigation brought by Royal Philips Electronics, a world leader in LED lighting ...
Nexxus Lighting,Inc.has announced a settlement agreement ending the pending patent litigation brought by Royal Philips Electronics. In connection with the settlement and patent license agreement: •Philips will grant Nexxus ...
Tags: Philips, Nexxus Lighting, Patent Litigation, LED
Nexxus Lighting and Royal Philips Electronics have settled patent litigation brought by Philips.Philips has granted Nexxus an ongoing,royalty-bearing license to LED luminaire and retrofit bulb technologies.Nexxus also finalized a$6 million ...
Tags: Nexxus Lighting, Philips, LED, Aston Capital, Patent Litigation
Samsung intends to fight Friday's landmark jury award of $1 billion to Apple over smartphone and tablet patent violations -- possibly for years. But while it fights on, Samsung and other cellphone makers are expected to make changes to ...
Tags: Samsung, Apple, landmark jury, smartphone, tablet, patent violation